1. Home
  2. DVA

as of 12-18-2025 3:39pm EST

$115.91
$2.51
-2.12%
Stocks Health Care Misc Health and Biotechnology Services Nasdaq

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Chart Type:
Time Range:
Founded: 1994 Country:
United States
United States
Employees: N/A City: DENVER
Market Cap: 8.4B IPO Year: 1995
Target Price: $145.00 AVG Volume (30 days): 975.3K
Analyst Decision: Hold Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 9.76 EPS Growth: 5.63
52 Week Low/High: $113.97 - $179.60 Next Earning Date: 10-29-2025
Revenue: $13,317,965,000 Revenue Growth: 5.14%
Revenue Growth (this year): 6.5% Revenue Growth (next year): 2.97%

AI-Powered DVA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 72.90%
72.90%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of DaVita Inc. (DVA)

DVA Oct 27, 2025

Avg Cost/Share

$135.36

Shares

401,514

Total Value

$54,347,248.68

Owned After

31,759,065

SEC Form 4

Latest DaVita Inc. News

DVA Breaking Stock News: Dive into DVA Ticker-Specific Updates for Smart Investing

All DVA News

Share on Social Networks: